Henry Schein - HSIC Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings or view top-rated stocks.

8 brokers have issued 12-month price targets for Henry Schein's shares. Their HSIC share price forecasts range from $70.00 to $99.00. On average, they expect the company's share price to reach $84.44 in the next twelve months. This suggests that the stock has a possible downside of 2.0%.
View analysts price targets for HSIC or view top-rated stocks among Wall Street analysts.

Henry Schein's stock was trading at $79.87 at the beginning of 2023. Since then, HSIC shares have increased by 7.9% and is now trading at $86.15.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our HSIC earnings forecast.

Henry Schein will be holding an earnings conference call on Thursday, February 16th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 877-660-6853 with passcode "13734321".

Henry Schein, Inc. (NASDAQ:HSIC) announced its quarterly earnings data on Tuesday, November, 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.16. The business had revenue of $3.18 billion for the quarter, compared to analysts' expectations of $2.94 billion. Henry Schein had a net margin of 5.06% and a trailing twelve-month return on equity of 15.48%. During the same period in the prior year, the business posted $1.03 earnings per share.
Read the conference call transcript.

Henry Schein's stock split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly created shares were issued to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Henry Schein declared that its Board of Directors has approved a stock buyback plan on Thursday, August 18th 2022, which authorizes the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board of directors believes its stock is undervalued.

Henry Schein updated its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share guidance of $4.79-$4.87 for the period, compared to the consensus EPS estimate of $4.84. The company issued revenue guidance of $12.59 billion-$12.71 billion, compared to the consensus revenue estimate of $12.89 billion.

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Henry Schein's stock is owned by a variety of institutional and retail investors. Top institutional investors include Pendal Group Ltd (3.09%), New York State Common Retirement Fund (0.67%), Ardevora Asset Management LLP (0.45%), Boston Trust Walden Corp (0.41%), Wedge Capital Management L L P NC (0.37%) and Sumitomo Mitsui Trust Holdings Inc. (0.30%). Insiders that own company stock include Bradford C Connett, Deborah Derby, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael S Ettinger, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HSIC stock can currently be purchased for approximately $86.15.

Henry Schein (NASDAQ:HSIC) has a market capitalization of $11.68 billion and generates $12.40 billion in revenue each year. The company earns $631.23 million in net income (profit) each year or $4.60 on an earnings per share basis.

The company employs 21,600 workers across the globe.

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The official website for the company is www.henryschein.com. The company can be reached via phone at (631) 843-5500, via email at steven.paladino@henryschein.com, or via fax at 631-843-5541.